For diabetes care, reducing financial barriers may include • Mr e ac ke pi nt go ri nasguolni ni sat nddr uogt hs eerx egml u pc ot sf reo- lmo wdeerdi un cgt mi b el edsi caantdi ocnoss itnschl ua rdiinngg, no er ws eGt tLi nPg- 1a low, fixed-dollar co-payment rather than one that varies with list price. • Epansssuerdinognthtoatthaenmy raetbtahteespoorindtioscfosualnet.s for medications employees pay for are • Mr e at ikni on pg artehgyu sl ac rr ecehneicnkg- su pe xs e, Hmepmt forgol mo bhi ni gAh 1dcetdeus ct itni bg l, egsl uocr ocmo -ept ae yr smaenndt s . •• CE on vs eu rr ii nn gg pa frfeovrednatbi vl ee aacncde sdsi at bo eFt De sA- -raepl aptreodv pe do ddieavt ri cyessefrovri cme sa.n a g i n g d i a b e t e s . • Wreocorkginnigzewdiltihfehsetyallethchpalanngseapnrdogortahmershineatolthbceanreefiptsa.rtners to incorporate CDC- • Psurorgviicdailnmg caoinvteernaagnecfeorcabraer.iatric surgery when recommended as well as post- For obesity care, reducing financial barriers may include • Ms haakr ii nn gg , aonrt is-eotbt iensgi t ay lmo we d, fi ci xaet di o- nd so l(lAa rO cMos- )p ae yx emme pn tt frraot hme rd et hd aunc toi bnlee st haant dv ca or iset s with list price. • Epansssuerdinognthtoatthaenmy raetbtahteespoorindtioscfosualnet.s for medications employees pay for are • Ms paekciina gl i srtesgeuxl ae rmcphtefcrko-mu phsi,gBhMdIesdcurcetei bn li ensg so ra nc od- cpoany smuel tnattsi .o n s w i t h o b e s i t y • Psurorgviicdailnmg caoinvteernaagnecfeorcabraer.iatric surgery when recommended as well as post- • Wreocorkginnigzewdiltihfehsetyallethchpalanngseapnrdogortahmershineatolthbceanreefipt.artners to incorporate CDC- Despite robust clinical evidence about their effectiveness, obesity treatments such as intensive behavioral interventions, AOMs and bariatric surgery are significantly un - derused among eligible people who would likely benefit from their use. 95 In addition tl oo s tshe es oi mf 3p-a5c%t oof f si un ci thi a tl rbe oa dt my ewnet isg ho tn i mo bpersoi vt ye, gi tl uhcaoss eb ei ne tno lsehr oa nwcne tahnadt Am1oCd, es sl ot ww ec oi gmh t- pplriocgartieosnsisoonfodf iparbeedteiasb, erteedsutcoettyhpee n2edeidabfoetregsl. ucose-lowering agents, and prevent the 96
95 https://www.healthaffairs.org/content/forefront/clinically-driven-payment-and-benefit-design-improve-health-equity-case-obesity 96 https://diabetesjournals.org/spectrum/article/30/4/237/32838/Treatment-of-Obesity-in-Patients-With-Diabetes
30
Made with FlippingBook Online newsletter maker